Literature DB >> 3836818

Some effects of melatonin and the control of its secretion in humans.

J Arendt, C Bojkowski, S Folkard, C Franey, V Marks, D Minors, J Waterhouse, R A Wever, C Wildgruber, J Wright.   

Abstract

Whether or not the pineal gland has a significant physiological role in humans is not known. There has nevertheless been speculation about the potential therapeutic use of melatonin (in view of its hypnotic and possible zeitgeber properties) in conditions such as insomnia and jet lag, and in shift-workers. Our work concerns the effects of melatonin administration in humans and the interactions between melatonin and other circadian variables. Chronic (one month), timed (1700 h), low-dose (2 mg daily) melatonin administration to normal subjects without environmental control consistently increased evening fatigue and slightly modified the 24 h prolactin rhythm without effect on cortisol, growth hormone, luteinizing hormone, thyroxine, testosterone or self-rated mood. In five out of 11 subjects the endogenous melatonin rhythm was advanced by one to three hours. During fractional desynchronization of circadian rhythms by increasing imposed 'day' length (26-29 h, 24 days, 500 lux), 5 mg melatonin per os at lights-out in two subjects resulted in better entrainment of the fatigue rhythm to the zeitgeber than in five out of six control subjects, without major consistent effects on other measured circadian variables. Using a new radioimmunoassay for 6-hydroxymelatonin sulphate (aMT6s), the major melatonin metabolite, we have shown that the urinary aMT6s rhythm is closely correlated to that of melatonin in plasma and is completely suppressed by an acute dose of atenolol (100 mg per os), a peripheral beta-adrenergic antagonist. During fractional desynchronization by increasing imposed 'day' length in one subject and decreasing imposed 'day' length in two subjects, the urinary aMT6s rhythm behaved similarly to that of core temperature. The results suggest that fatigue (or alertness) may be entrained by melatonin, but whether critical performance rhythms can be suitably manipulated remains to be clarified. It is likely that melatonin production is linked to the so-called 'strong' circadian oscillator.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3836818     DOI: 10.1002/9780470720981.ch16

Source DB:  PubMed          Journal:  Ciba Found Symp        ISSN: 0300-5208


  22 in total

1.  Fatigue and melatonin in Parkinson's disease.

Authors:  P H Critchley; G P Malcolm; P N Malcolm; W R Gibb; J Arendt; J D Parkes
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-01       Impact factor: 10.154

2.  Comment to the paper of Medeiros CAM, et al. (2007) J Neurol 254:459-464.

Authors:  Elisabeth Fertl
Journal:  J Neurol       Date:  2008-02-21       Impact factor: 4.849

3.  A three pulse phase response curve to three milligrams of melatonin in humans.

Authors:  Helen J Burgess; Victoria L Revell; Charmane I Eastman
Journal:  J Physiol       Date:  2007-11-15       Impact factor: 5.182

Review 4.  Circadian rhythm sleep disorders: pathophysiology and potential approaches to management.

Authors:  N Zisapel
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

Review 5.  Light, melatonin and the sleep-wake cycle.

Authors:  G M Brown
Journal:  J Psychiatry Neurosci       Date:  1994-11       Impact factor: 6.186

6.  Melatonin treatment for eastward and westward travel preparation.

Authors:  Michel A Paul; James C Miller; Gary W Gray; Ryan J Love; Harris R Lieberman; Josephine Arendt
Journal:  Psychopharmacology (Berl)       Date:  2009-12-15       Impact factor: 4.530

Review 7.  Optimal dosages for melatonin supplementation therapy in older adults: a systematic review of current literature.

Authors:  Esmée M S Vural; Barbara C van Munster; Sophia E de Rooij
Journal:  Drugs Aging       Date:  2014-06       Impact factor: 3.923

8.  Melatonin advances the circadian timing of EEG sleep and directly facilitates sleep without altering its duration in extended sleep opportunities in humans.

Authors:  Shantha M W Rajaratnam; Benita Middleton; Barbara M Stone; Josephine Arendt; Derk-Jan Dijk
Journal:  J Physiol       Date:  2004-09-30       Impact factor: 5.182

9.  Sleep and circadian abnormalities in patients with cirrhosis: features of delayed sleep phase syndrome?

Authors:  Sara Montagnese; Benita Middleton; Ali R Mani; Debra J Skene; Marsha Y Morgan
Journal:  Metab Brain Dis       Date:  2009-09       Impact factor: 3.584

Review 10.  Effect of Light and Melatonin and Other Melatonin Receptor Agonists on Human Circadian Physiology.

Authors:  Jonathan S Emens; Helen J Burgess
Journal:  Sleep Med Clin       Date:  2015-09-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.